Provided by Tiger Fintech (Singapore) Pte. Ltd.

Omeros

3.20
-0.1200-3.61%
Volume:1.70M
Turnover:5.51M
Market Cap:187.50M
PE:-1.21
High:3.42
Open:3.30
Low:3.17
Close:3.32
Loading ...

Omeros submission adds another 2026 catalyst, says H.C. Wainwright

TIPRANKS
·
27 Jun

Omeros Corporation Submits Narsoplimab Marketing Authorization Application to European Medicines Agency for TA-TMA Treatment

Reuters
·
27 Jun

Omeros Corp - Narsoplimab Maa Review Procedure Begins in Mid-July

THOMSON REUTERS
·
27 Jun

Omeros Corp - Pdufa Target Action Date for Narsoplimab Set for September 25, 2025

THOMSON REUTERS
·
27 Jun

Omeros Submits Narsoplimab Marketing Authorization Application to the European Medicines Agency for the Treatment of Ta-Tma

THOMSON REUTERS
·
27 Jun

HC Wainwright Initiates Coverage on Omeros With Buy Rating, $9 Price Target

MT Newswires Live
·
10 Jun

Omeros Initiated at Buy by HC Wainwright & Co.

Dow Jones
·
10 Jun

Omeros initiated with a Buy at H.C. Wainwright

TIPRANKS
·
10 Jun

Omeros Stock Falls to 52-Week Low on 1Q Results, Company Pauses Trial

Dow Jones
·
17 May

Omeros Corp reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
16 May

BRIEF-Omeros Corporation Q1 Net Income USD -33.5 Million

Reuters
·
16 May

Omeros Q1 EPS $(0.58) Misses $(0.57) Estimate

Benzinga
·
16 May

Omeros Corporation Reports Q1 2025 Net Loss of $33.5M, EPS Improves to $0.58 from $0.63; OMIDRIA Royalties Drop to $6.7M

Reuters
·
16 May

Omeros Corporation Q1 EPS USD -0.58

THOMSON REUTERS
·
16 May

Omeros Corp expected to post a loss of 57 cents a share - Earnings Preview

Reuters
·
14 May

Omeros Is Maintained at Buy by D. Boral Capital

Dow Jones
·
13 May

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
13 May

Omeros Corporation to Announce First Quarter Financial Results

Reuters
·
13 May

Top Midday Decliners

MT Newswires Live
·
13 May

Omeros Shares Drop After Notes Conversions

Dow Jones
·
13 May